LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article ; Online: Acute traumatic brain injury in frail patients: the next pandemic.

    Baggiani, Marta / Guglielmi, Angelo / Citerio, Giuseppe

    Current opinion in critical care

    2022  Volume 28, Issue 2, Page(s) 166–175

    Abstract: Purpose of review: To highlight recent findings on the evaluation and impact of frailty in the management of patients with traumatic brain injury (TBI).: Recent findings: Frailty is not a direct natural consequence of aging. Rather, it commonly ... ...

    Abstract Purpose of review: To highlight recent findings on the evaluation and impact of frailty in the management of patients with traumatic brain injury (TBI).
    Recent findings: Frailty is not a direct natural consequence of aging. Rather, it commonly results from the intersection of age-related decline with chronic diseases and conditions. It is associated with adverse outcomes such as institutionalization, falls, and worsening health status. Growing evidence suggests that frailty should be a key consideration both in care planning and in adverse outcome prevention. The prevalence of elderly patients with TBI is increasing, and low-energy trauma (i.e., ground or low-level falls, which are typical in frail patients) is the major cause. Establishing the real incidence of frailty in TBI requires further studies. Failure to detect frailty potentially exposes patients to interventions that may not benefit them, and may even harm them. Moreover, considering patients as 'nonfrail' purely on the basis of their age is unacceptable. The future challenge is to shift to a new clinical paradigm characterized by more appropriate, goal-directed care of frail patients.
    Summary: The current review highlights the crucial importance of frailty evaluation in TBI, also given the changing epidemiology of this condition. To ensure adequate assessment, prevention and management, both in and outside hospital, there is an urgent need for a valid screening tool and a specific frailty-based and comorbidity-based clinical approach.
    MeSH term(s) Aged ; Brain Injuries, Traumatic/epidemiology ; Brain Injuries, Traumatic/therapy ; Comorbidity ; Frail Elderly ; Frailty/epidemiology ; Geriatric Assessment ; Humans ; Pandemics
    Language English
    Publishing date 2022-01-25
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1235629-3
    ISSN 1531-7072 ; 1070-5295
    ISSN (online) 1531-7072
    ISSN 1070-5295
    DOI 10.1097/MCC.0000000000000915
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cerebral flow variation at different intra-aortic balloon settings in cardiogenic shock.

    Colombo, Costanza Natalia Julia / Guglielmi, Angelo / Mojoli, Francesco / Tavazzi, Guido

    European heart journal. Cardiovascular Imaging

    2022  Volume 23, Issue 6, Page(s) e270

    MeSH term(s) Aorta ; Humans ; Intra-Aortic Balloon Pumping ; Myocardial Infarction ; Shock, Cardiogenic/diagnostic imaging ; Shock, Cardiogenic/therapy
    Language English
    Publishing date 2022-03-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 2638345-7
    ISSN 2047-2412 ; 2047-2404
    ISSN (online) 2047-2412
    ISSN 2047-2404
    DOI 10.1093/ehjci/jeac054
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Treatments for intracranial hypertension in acute brain-injured patients: grading, timing, and association with outcome. Data from the SYNAPSE-ICU study.

    Robba, Chiara / Graziano, Francesca / Guglielmi, Angelo / Rebora, Paola / Galimberti, Stefania / Taccone, Fabio S / Citerio, Giuseppe

    Intensive care medicine

    2023  Volume 49, Issue 1, Page(s) 50–61

    Abstract: Purpose: Uncertainties remain about the safety and efficacy of therapies for managing intracranial hypertension in acute brain injured (ABI) patients. This study aims to describe the therapeutical approaches used in ABI, with/without intracranial ... ...

    Abstract Purpose: Uncertainties remain about the safety and efficacy of therapies for managing intracranial hypertension in acute brain injured (ABI) patients. This study aims to describe the therapeutical approaches used in ABI, with/without intracranial pressure (ICP) monitoring, among different pathologies and across different countries, and their association with six months mortality and neurological outcome.
    Methods: A preplanned subanalysis of the SYNAPSE-ICU study, a multicentre, prospective, international, observational cohort study, describing the ICP treatment, graded according to Therapy Intensity Level (TIL) scale, in patients with ABI during the first week of intensive care unit (ICU) admission.
    Results: 2320 patients were included in the analysis. The median age was 55 (I-III quartiles = 39-69) years, and 800 (34.5%) were female. During the first week from ICU admission, no-basic TIL was used in 382 (16.5%) patients, mild-moderate in 1643 (70.8%), and extreme in 295 cases (eTIL, 12.7%). Patients who received eTIL were younger (median age 49 (I-III quartiles = 35-62) vs 56 (40-69) years, p < 0.001), with less cardiovascular pre-injury comorbidities (859 (44%) vs 90 (31.4%), p < 0.001), with more episodes of neuroworsening (160 (56.1%) vs 653 (33.3%), p < 0.001), and were more frequently monitored with an ICP device (221 (74.9%) vs 1037 (51.2%), p < 0.001). Considerable variability in the frequency of use and type of eTIL adopted was observed between centres and countries. At six months, patients who received no-basic TIL had an increased risk of mortality (Hazard ratio, HR = 1.612, 95% Confidence Interval, CI = 1.243-2.091, p < 0.001) compared to patients who received eTIL. No difference was observed when comparing mild-moderate TIL with eTIL (HR = 1.017, 95% CI = 0.823-1.257, p = 0.873). No significant association between the use of TIL and neurological outcome was observed.
    Conclusions: During the first week of ICU admission, therapies to control high ICP are frequently used, especially mild-moderate TIL. In selected patients, the use of aggressive strategies can have a beneficial effect on six months mortality but not on neurological outcome.
    MeSH term(s) Humans ; Female ; Middle Aged ; Male ; Prospective Studies ; Intracranial Pressure ; Intensive Care Units ; Monitoring, Physiologic ; Intracranial Hypertension/etiology ; Intracranial Hypertension/therapy ; Brain ; Brain Injuries, Traumatic/complications ; Brain Injuries, Traumatic/therapy ; Glasgow Coma Scale
    Language English
    Publishing date 2023-01-09
    Publishing country United States
    Document type Observational Study ; Journal Article
    ZDB-ID 80387-x
    ISSN 1432-1238 ; 0340-0964 ; 0342-4642 ; 0935-1701
    ISSN (online) 1432-1238
    ISSN 0340-0964 ; 0342-4642 ; 0935-1701
    DOI 10.1007/s00134-022-06937-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Intracranial Pressure Monitoring Practice, Treatment, and Effect on Outcome in Aneurysmal Subarachnoid Hemorrhage.

    Baggiani, Marta / Graziano, Francesca / Rebora, Paola / Robba, Chiara / Guglielmi, Angelo / Galimberti, Stefania / Giussani, Carlo / Suarez, Jose I / Helbok, Raimund / Citerio, Giuseppe

    Neurocritical care

    2022  Volume 38, Issue 3, Page(s) 741–751

    Abstract: Background: Intracranial pressure (ICP) monitoring and its management in aneurysmal subarachnoid hemorrhage (aSAH) is variable worldwide. The present study aimed to explore the practice of ICP monitoring, its variability across countries, and the ... ...

    Abstract Background: Intracranial pressure (ICP) monitoring and its management in aneurysmal subarachnoid hemorrhage (aSAH) is variable worldwide. The present study aimed to explore the practice of ICP monitoring, its variability across countries, and the association with 6-month outcomes in aSAH.
    Methods: This was a preplanned subanalysis of SYNAPSE-ICU, a multicenter, international, prospective, observational cohort study focused on patients diagnosed with aSAH. We evaluated the variability in ICP monitoring across countries through a logistic regression model adjusted for case-mix and considered countries as a random effect. The association between ICP probe insertion and 6-month mortality and a poor neurological outcome, defined as an Glasgow Outcome Score Extended ≤ 4, was assessed by using a propensity score approach.
    Results: A total of 423 patients with aSAH from 92 centers across 32 countries were included in this analysis. ICP monitoring was used in 295 (69.7%) patients. Significant between-country variability in ICP insertion was observed, with an incidence ranging between 4.7% and 79.9% (median odd ratio 3.04). The median duration of ICP monitoring was 12 days (first quartile [Q1] through third quartile [Q3] range 8-18), with an overall daily median ICP value of 14 mm Hg (Q1-Q3 10-19) and a median maximum value of 21 mm Hg (Q1-Q3 16-30). Patients monitored with ICP received more aggressive therapy treatments compared with non-monitored patients (therapy intensity level, TIL, score 10.33 [standard deviation 3.61] vs. 6.3 [standard deviation 4.19], p < 0.001). In more severe patients, ICP monitoring was significantly associated with better 6-month outcome (poor neurological outcome: odds ratio 0.14, 95% confidence interval 0.02-0.53, p = 0.0113; mortality: hazard ratio 0.25, 95% confidence interval 0.13-0.49, p < 0.0001). However, no significant effect was observed in patients with both reactive pupils.
    Conclusions: Our cohort demonstrated high variability in ICP insertion practice among countries. A more aggressive treatment approach was applied in ICP-monitored patients. In patients with severe aSAH, ICP monitoring might reduce unfavorable outcomes and mortality at 6 months.
    MeSH term(s) Humans ; Subarachnoid Hemorrhage/etiology ; Treatment Outcome ; Intracranial Pressure ; Prospective Studies ; Monitoring, Physiologic
    Language English
    Publishing date 2022-12-05
    Publishing country United States
    Document type Observational Study ; Multicenter Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2381896-7
    ISSN 1556-0961 ; 1541-6933
    ISSN (online) 1556-0961
    ISSN 1541-6933
    DOI 10.1007/s12028-022-01651-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Safety and Effectiveness of Veno-Venous Extracorporeal Membrane Oxygenation Combined With Continuous Renal Replacement Therapy.

    Ferrari, Fiorenza / Manera, Miriam / Villa, Gianluca / De Silvestri, Annalisa / Bianchi Bosisio, Nicholas Simone Manuel / Guglielmi, Angelo / Mazza, Giovanni / Colombo, Costanza / D'Auria, Luigi / Rampino, Teresa / Belliato, Mirko

    ASAIO journal (American Society for Artificial Internal Organs : 1992)

    2022  Volume 69, Issue 4, Page(s) 360–365

    Abstract: Patients receiving extracorporeal membrane oxygenation (ECMO) often suffer from acute kidney injury (AKI), requiring continuous renal replacement therapy (CRRT). In our clinical practice, we connected the inlet line of a CRRT machine to the ... ...

    Abstract Patients receiving extracorporeal membrane oxygenation (ECMO) often suffer from acute kidney injury (AKI), requiring continuous renal replacement therapy (CRRT). In our clinical practice, we connected the inlet line of a CRRT machine to the postoxygenator Luer port and the outlet line to the inlet Luer port of the oxygenator. In this case series, we analyzed the interaction between the two machines. Between December 31, 2017, and December 31, 2019, we enrolled 15 patients from the ICU of the San Matteo Hospital, Pavia, Italy. All of them suffered from severe acute respiratory distress syndrome and AKI stage 3. We analyzed 570 hours of CRRT combined with venovenous ECMO and collected 261,751 CRRT data. No discontinuation of CRRT occurred before 48 hours. Most of the alarms occurred within 24 hours of the connection: 22/10,831 (0.2%) showed an outranged inlet pressure, 11/10831 (0.11%) showed an outranged transmembrane pressure, 14/10,831 (0.13%) showed an outranged inlet pressure, and 138/10,831 (1.27%) an outranged effluent pressure. The rate per minute set for the ECMO circuit was correlated with the inlet (β = 5.38; CI, 95% 1.42-9.35; p = 0.008), transmembrane (β = 4.6; CI, 95% 1.97-7.24; p = 0.001), effluent (β = 3.02; CI, 95% 1.15-4.90; p = 0.002), and outlet pressures (β = 597; CI, 95% 2.31-9.63; p = 0.001) of the CRRT circuit. We reported that our configuration could be safe and effective, however well-designed studies would be beneficial for determining the potential risks and benefits.
    MeSH term(s) Humans ; Continuous Renal Replacement Therapy ; Extracorporeal Membrane Oxygenation/adverse effects ; Acute Kidney Injury/therapy ; Respiratory Distress Syndrome ; Italy ; Renal Replacement Therapy ; Retrospective Studies
    Language English
    Publishing date 2022-10-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 759982-1
    ISSN 1538-943X ; 0162-1432 ; 1058-2916
    ISSN (online) 1538-943X
    ISSN 0162-1432 ; 1058-2916
    DOI 10.1097/MAT.0000000000001815
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Coronavirus disease 2019 in critically ill patients: can we re-program the immune system? A primer for Intensivists.

    Ferrari, Fiorenza / Visconti, Federico / De Amici, Mara / Guglielmi, Angelo / Colombo, Costanza N / Belliato, Mirko / Ronco, Claudio

    Minerva anestesiologica

    2020  Volume 86, Issue 11, Page(s) 1214–1233

    Abstract: In December 2019, Coronavirus disease 2019 (COVID-19) emerged in Wuhan and rapidly spread around the word. The immune response is essential to control and eliminate CoV infections, however, multiorgan damage might be due to direct SARS-CoV2 action ... ...

    Abstract In December 2019, Coronavirus disease 2019 (COVID-19) emerged in Wuhan and rapidly spread around the word. The immune response is essential to control and eliminate CoV infections, however, multiorgan damage might be due to direct SARS-CoV2 action against the infected organ cells, as well as an imbalanced host immune response. In effect, a "cytokines storm" and an impaired innate immunity were found in the COVID-19 critically ill patients. In this review, we summarized the virus immune response steps, underlying the relevance of introducing the measurement of plasma cytokine levels and of circulating lymphocyte subsets in clinical practice for the follow-up of critically ill COVID-19 patients and support new therapy.
    MeSH term(s) Adaptive Immunity ; COVID-19/immunology ; COVID-19/therapy ; Critical Care ; Critical Illness ; Cytokine Release Syndrome ; Humans ; Immunity, Innate ; Immunotherapy
    Keywords covid19
    Language English
    Publishing date 2020-08-04
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 123584-9
    ISSN 1827-1596 ; 0026-4717 ; 0375-9393
    ISSN (online) 1827-1596
    ISSN 0026-4717 ; 0375-9393
    DOI 10.23736/S0375-9393.20.14663-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A simple prognostic score for COVID-19 hospitalized patients developing deep vein thrombosis.

    Bozzani, Antonio / Arici, Vittorio / Tavazzi, Guido / Boschini, Stefano / Guglielmi, Angelo / Mazza, Giovanni / Mojoli, Francesco / Bruno, Raffaele / Ragni, Franco / Sterpetti, Antonio V

    Phlebology

    2021  Volume 36, Issue 10, Page(s) 835–840

    Abstract: Objective: The aim of our study was to analyze the specificity, accuracy and sensitivity of a simple, easy to calculate, prognostic score for hospitalized COVID19 patients developing deep vein thrombosis.: Methods: From March 1st to April 28th, 942 ... ...

    Abstract Objective: The aim of our study was to analyze the specificity, accuracy and sensitivity of a simple, easy to calculate, prognostic score for hospitalized COVID19 patients developing deep vein thrombosis.
    Methods: From March 1st to April 28th, 942 COVID-19 patients with severe symptoms were admitted to the hospital San Matteo of Pavia-Italy. Thirty two patients (3.4%) developed deep vein thrombosis during hospitalization. In all patients hemostatic and inflammatory parameters were abnormal. A simple prognostic score was developed based on the presence of specific co morbidities and D-dimers levels (quick San Matthew Score-quick SMS).
    Results: Nine patients died in a condition of multiple organ failure, 23 patients (71.9%) survived and left the hospital in good general conditions. The developed score was based simply on two parameters: 1) presence of four specific co morbidities and 2)systemic levels of D-Dimers. The quick San Matthew Score resulted in a sensitivity, specificity and overall accuracy of more than 90% (94%, 92%,93% respectively) and compared favorably with other scores. The score was prospectively validated in 100 COVID19 patients who developed deep vein thrombosis collected from the literature and prospectively confirmed in our hospital.
    Conclusions: The findings of our study underline the importance of an immediate aggressive therapeutic approach for moderate and high-risk patients with COVID19 infection. The quick SMS score may help to identify patients at high risk for mortality and to follow the clinical outcome of the patient. A simple, easy to calculate prognostic score may also facilitate communication among health workers.
    MeSH term(s) COVID-19 ; Hospitalization ; Humans ; Prognosis ; SARS-CoV-2 ; Venous Thrombosis/diagnosis ; Venous Thrombosis/epidemiology ; Venous Thrombosis/therapy
    Language English
    Publishing date 2021-07-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 645172-x
    ISSN 1758-1125 ; 0268-3555
    ISSN (online) 1758-1125
    ISSN 0268-3555
    DOI 10.1177/02683555211030099
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists

    Ferrari, Fiorenza / Visconti, Federico / De Amici, Mara / Guglielmi, Angelo / Colombo, Costanza N J / Belliato, Mirko / Ronco, Claudio

    Minerva anestesiol

    Abstract: In December 2019, Coronavirus Disease 2019 (COVID-19) emerged in Wuhan and rapidly spread around the word. The immune response is essential to control and eliminate CoV infections, however, multiorgan damage might be due to direct SARS-CoV2 action ... ...

    Abstract In December 2019, Coronavirus Disease 2019 (COVID-19) emerged in Wuhan and rapidly spread around the word. The immune response is essential to control and eliminate CoV infections, however, multiorgan damage might be due to direct SARS-CoV2 action against the infected organ cells, as well as an imbalanced host immune response. In effect, a "cytokines storm" and an impaired innate immunity were found in the COVID-19 critically ill patients. In this review, we summarize the virus immune response steps, underlying the relevance of introducing the measurement of plasma cytokine levels and of circulating lymphocyte subsets in clinical practice for the follow-up of critically ill COVID-19 patients and support new therapy.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #697072
    Database COVID19

    Kategorien

  9. Article ; Online: Coronavirus disease 2019 (COVID-19) in critically ill patients

    Ferrari, Fiorenza / Visconti, Federico / De Amici, Mara / Guglielmi, Angelo / J Colombo, Costanza N / Belliato, Mirko / Ronco, Claudio

    can we re-program the immune system? A primer for intensivists

    2020  

    Keywords covid19
    Language English
    Publishing country it
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC®2 Membrane in Patients with Septic Shock.

    Ferrari, Fiorenza / Husain-Syed, Faeq / Milla, Paola / Lorenzin, Anna / Scudeller, Luigia / Sartori, Marco / Gramaticopolo, Silvia / D'Auria, Luigi / Guglielmi, Angelo / Cornara, Pietro / De Rosa, Silvia / Zanella, Monica / Corradi, Valentina / De Cal, Massimo / Danzi, Vinicio / Giavarina, Davide / Brendolan, Alessandra / Mojoli, Francesco / Arpicco, Silvia /
    Ronco, Claudio

    Blood purification

    2022  Volume 51, Issue 11, Page(s) 912–922

    Abstract: Introduction: At the time of renal replacement therapy, approximately 20% of critically ill patients have septic shock. In this study, medium cutoff (MCO) continuous venovenous hemodialysis (CVVHD) was compared to high-flux membrane continuous ... ...

    Abstract Introduction: At the time of renal replacement therapy, approximately 20% of critically ill patients have septic shock. In this study, medium cutoff (MCO) continuous venovenous hemodialysis (CVVHD) was compared to high-flux membrane continuous venovenous hemodiafiltration (CVVHDF) in terms of hemodynamic improvement, efficiency, middle molecule removal, and inflammatory system activation.
    Methods: This is a monocenter crossover randomized study. Between December 31, 2017, and December 31, 2019, 20 patients with septic shock and stage 3 acute kidney injury (AKI) admitted to 2 Italian ICUs were enrolled. All patients underwent CVVHD with Ultraflux® EMiC®2 and CVVHDF with AV1000S® without washout. Each treatment lasted 24 h.
    Results: Compared to AV1000S®-CVVHDF, EMIC®2-CVVHD normalized cardiac index (β = -0.64; p = 0.02) and heart rate (β = 5.72; p = 0.01). Interleukin-8 and myeloperoxidase removal were greater with AV1000S®-CVVHDF than with EMiC®2-CVVHD (β = 0.35; p < 0.001; β = 0.43; p = 0.03, respectively). Leukocytosis improved over 24 h in EMiC®2-CVVHD-treated patients (β = 4.13; p = 0.03), whereas procalcitonin levels decreased regardless of the modality (β = 0.89; p = 0.01) over a 48-h treatment period. Reduction rates, instantaneous plasmatic clearance of urea, creatinine, and β2-microglobulin were similar across modalities. β2-Microglobulin removal efficacy was greater in the EMiC®2 group (β = 0-2.88; p = 0.002), while albumin levels did not differ. Albumin was undetectable in the effluent in both treatments.
    Discussion: In patients with septic shock and severe AKI, the efficacy of uremic toxin removal was comparable between MCO-CVVHD and CVVHDF. Further, MCO-CVVHD was associated with improved hemodynamics. Fraction of filtration and transmembrane pressure reduction and the maintenance of equal efficacy might be the key features of CVVHD with MCO membranes in critically ill patients.
    MeSH term(s) Humans ; Continuous Renal Replacement Therapy ; Shock, Septic/therapy ; Shock, Septic/etiology ; Critical Illness ; Renal Dialysis ; Acute Kidney Injury/therapy ; Albumins ; Hemodiafiltration/adverse effects
    Chemical Substances MCO (56369-20-1) ; Albumins
    Language English
    Publishing date 2022-03-09
    Publishing country Switzerland
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 605548-5
    ISSN 1421-9735 ; 0253-5068
    ISSN (online) 1421-9735
    ISSN 0253-5068
    DOI 10.1159/000522321
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top